Recently, we have analyzed KLK5 mRNA expression by quantitative polymerase chain reaction (qPCR) in a homogenous cohort encompassing only patients afflicted with advanced high-grade serous ovarian cancer [31]. Here, KLK5 is linked to ovarian serous adenocarcinoma.